Refine Search
(4)
(12)
(29)
(81)

Immunology

GlobalData provides unique and market-leading data and insights into the immunology market. Browse or search our Report Store for the latest comprehensive reports, market data, analysis and survey findings alongside industry information on key companies, markets and financial deals.

NEW Myasthenia Gravis: Opportunity Analysis and Forecasts to 2028

  • $10,995
  • October 2019
Add to Basket Quick View Add to Saved List

Myasthenia gravis (MG) is a rare chronic autoimmune and neuromuscular disorder. Most patients experience weakness of the muscles around the eye, which can cause drooping of the eyelids and blurred vision. In other types of MG, weakness can exte...

NEW Axial Spondyloarthritis: Global Drug Forecast and Market Analysis to 2028

  • $10,995
  • October 2019
Add to Basket Quick View Add to Saved List

Axial spondyloarthritis (axSpA) is a disease group encompassing both ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA). These conditions are chronic, autoinflammatory disorders of the sacroiliac joints and spin...

Axial Spondyloarthritis: Epidemiology Forecast to 2028

  • $3,995
  • September 2019
Add to Basket Quick View Add to Saved List

Axial spondyloarthritis (AxSpA) is a condition characterized by predominant inflammation in the spine and/or sacroiliac joints, with inflammatory back pain and stiffness that may be improved with exercise. Based on sacroiliac changes on convent...

Myasthenia Gravis: Epidemiology Forecast to 2028

  • $3,995
  • September 2019
Add to Basket Quick View Add to Saved List

Myasthenia gravis (MG) is the most common neuromuscular junction disorder, and is characterized by a fluctuating degree and variable combination of weakness in ocular, bulbar, limb, and respiratory muscles (Lai and Tseng, 2010). In this disease...

Allergic Diseases: Pipeline Offers Novel Approaches to Treat Increasingly Prevalent Conditions, with Strong Presence of Cytokine Mediators Among First-in-Class Products

  • $6,995
  • June 2019
Add to Basket Quick View Add to Saved List

An allergy or allergic disease is a condition that arises from an adverse reaction to an exogenous antigen, a substance that invokes an immunological response. These conditions are extremely common. The number of people diagnosed with allergic ...

Systemic Lupus Erythematosus: Programs Targeting Cytokine and Growth Factor Signaling Dominate First-in-Class Pipeline

  • $6,995
  • June 2019
Add to Basket Quick View Add to Saved List

Systemic lupus erythematosus (SLE) is a systemic inflammatory autoimmune disease that can affect any organ or tissue and is the prototypic autoimmune disease. While SLE can affect multiple major organ systems in the body, one of its most severe...

Drug Hypersensitivity Reactions Global Clinical Trials Review, H1, 2019

  • $2,500
  • May 2019
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Drug Hypersensitivity Reactions Global Clinical Trials Review, H1, 2019" provides an overview of Drug Hypersensitivity Reactions clinical trials scenario. This report provides top line data relating...

Corneal Graft Rejection Global Clinical Trials Review, H1, 2019

  • $2,500
  • April 2019
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Corneal Graft Rejection Global Clinical Trials Review, H1, 2019" provides an overview of Corneal Graft Rejection clinical trials scenario. This report provides top line data relating to the clinical...

Cutaneous Lupus Erythematosus Global Clinical Trials Review, H1, 2019

  • $2,500
  • April 2019
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Cutaneous Lupus Erythematosus Global Clinical Trials Review, H1, 2019" provides an overview of Cutaneous Lupus Erythematosus clinical trials scenario. This report provides top line data relating to ...

Churg-Strauss Syndrome Global Clinical Trials Review, H1, 2019

  • $2,500
  • April 2019
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Churg-Strauss Syndrome Global Clinical Trials Review, H1, 2019" provides an overview of Churg-Strauss Syndrome clinical trials scenario. This report provides top line data relating to the clinical t...

Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Global Clinical Trials Review, H1, 2019

  • $2,500
  • April 2019
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Global Clinical Trials Review, H1, 2019" provides an overview of Chronic Cutaneous Lupus Erythematosus (CCLE) / Disco...

Chronic Inflammation Global Clinical Trials Review, H1, 2019

  • $2,500
  • April 2019
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Chronic Inflammation Global Clinical Trials Review, H1, 2019" provides an overview of Chronic Inflammation clinical trials scenario. This report provides top line data relating to the clinical trial...

Rheumatoid Arthritis: Global Drug Forecast and Market Analysis to 2027

  • $10,995
  • January 2019
Add to Basket Quick View Add to Saved List

Rheumatoid arthritis (RA) is an autoimmune disease that, due to a complex interplay of environmental, immunological, and genetic factors, causes chronic inflammation and progressive deformity of the joints over time.

In 2017, the diagnose...

Rheumatoid Arthritis: Epidemiology Forecast to 2027

  • $3,995
  • January 2019
Add to Basket Quick View Add to Saved List

Rheumatoid arthritis (RA) is an autoimmune disease characterized by inflammation of the joints, bone and cartilage erosion, and joint deformity. Additionally, the condition manifests itself in multiple joints in the body. In RA, the body’s immu...

Plaque Psoriasis: Global Drug Forecast and Market Analysis to 2027

  • $10,995
  • December 2018
Add to Basket Quick View Add to Saved List

Psoriasis is an incurable, chronic and systemic inflammatory skin disorder with a prevalence of 2–3% worldwide. The exact causes of psoriasis is unknown, although it is believed that environmental factors, skin barrier disruptions, and immune d...

Join our mailing list
Find out first about the latest reports and offers.